Connection

Contact Us
If you have any questions or feedback please contact us.

Search Results to David B Badesch

This is a "connection" page, showing the details of why an item matched the keywords from your search.

Search Results

Badesch, David

One or more keywords matched the following items that are connected to Badesch, David

Item Type	Name
Academic Article	Bosentan therapy for pulmonary arterial hypertension.
Academic Article	Pulmonary hypertension associated with connective tissue disease.
Academic Article	Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension: a 1-year follow-up study.
Academic Article	Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan.
Academic Article	ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association.
Academic Article	Continuous infusion of epoprostenol improves the net balance between pulmonary endothelin-1 clearance and release in primary pulmonary hypertension.
Academic Article	ARIES-3: ambrisentan therapy in a diverse population of patients with pulmonary hypertension.
Academic Article	Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trial.
Academic Article	Sitaxsentan for the treatment of pulmonary arterial hypertension: a 1-year, prospective, open-label observation of outcome and survival.
Academic Article	Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2.
Academic Article	Ambrisentan therapy in patients with pulmonary arterial hypertension who discontinued bosentan or sitaxsentan due to liver function test abnormalities.
Concept	Endothelin-1
Academic Article	Perspectives on oral pulmonary hypertension therapies recently approved by the U.S. Food and Drug Administration.
Academic Article	Reply: Perspectives on Oral Pulmonary Hypertension Therapies Recently Approved by the U.S. Food and Drug Administration.
Academic Article	Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary hypertension: a placebo-controlled study.
Concept	Endothelin Receptor Antagonists
Concept	Endothelin A Receptor Antagonists

Search Criteria

Endothelin 1